We are live on ! Find out more
PM

Penbrook Management Portfolio holdings

AUM $157M
1-Year Est. Return 46.57%
This Fund
S&P 500
This Quarter Est. Return
+12.82%
1 Year Est. Return
+46.57%
3 Year Est. Return
+102.93%
5 Year Est. Return
+150.44%
10 Year Est. Return
AUM
$167M
AUM Growth
+$27.9M
Cap. Flow
+$6.46M
Cap. Flow %
3.87%
Top 10 Hldgs %
39.22%
Holding
107
New
5
Increased
23
Reduced
37
Closed
3

Sector Composition

Rank Sector Weight
1 Technology 22.08%
2 Healthcare 18.21%
3 Energy 11.75%
4 Industrials 10.02%
5 Financials 9.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CEMI
51
DELISTED
Chembio diagnostics, Inc.
CEMI
$1.05M 0.63%
355,270
+6,310
+2% +$22K
STKS icon
52
The ONE Group
STKS
$54.6M
$1.05M 0.63%
94,905
-1,400
-1% -$14.2K
IDN icon
53
Intellicheck
IDN
$76.8M
$1.04M 0.63%
+124,830
New +$1.02M
FIX icon
54
Comfort Systems
FIX
$62.3B
$1.01M 0.6%
12,765
-250
-2% -$20.4K
FBP icon
55
First Bancorp
FBP
$4.43B
$993K 0.6%
83,300
BRK.B icon
56
Berkshire Hathaway Class B
BRK.B
$1.11T
$938K 0.56%
3,375
-200
-6% -$55.9K
RSP icon
57
Invesco S&P 500 Equal Weight ETF
RSP
$98.1B
$928K 0.56%
6,160
+670
+12% +$99.7K
FISV
58
Fiserv Inc
FISV
$29B
$838K 0.5%
7,841
-1,000
-11% -$116K
BKI
59
DELISTED
Black Knight, Inc. Common Stock
BKI
$838K 0.5%
10,746
META icon
60
Meta Platforms (Facebook)
META
$1.5T
$835K 0.5%
2,400
PIM
61
Franklin Master Intermediate Income Trust
PIM
$150M
$826K 0.5%
197,152
ABBV icon
62
AbbVie
ABBV
$433B
$818K 0.49%
7,262
+164
+2% +$18.5K
HESM icon
63
Hess Midstream
HESM
$5.23B
$818K 0.49%
32,380
+4,700
+17% +$113K
IBB icon
64
iShares Biotechnology ETF
IBB
$9.18B
$751K 0.45%
4,590
+660
+17% +$102K
REGN icon
65
Regeneron Pharmaceuticals
REGN
$78.2B
$710K 0.43%
1,272
+462
+57% +$234K
WMB icon
66
Williams Companies
WMB
$86.1B
$710K 0.43%
26,730
+1,700
+7% +$43.5K
FAF icon
67
First American
FAF
$7.7B
$676K 0.41%
10,850
DM
68
DELISTED
Desktop Metal, Inc.
DM
$676K 0.41%
5,875
-25
-0.4% -$3.28K
BLDR icon
69
Builders FirstSource
BLDR
$7.8B
$660K 0.4%
15,478
VET icon
70
Vermilion Energy
VET
$1.76B
$631K 0.38%
71,950
GLP icon
71
Global Partners
GLP
$1.69B
$596K 0.36%
22,980
+300
+1% +$7.36K
NVS icon
72
Novartis
NVS
$292B
$589K 0.35%
6,460
EVT icon
73
Eaton Vance Tax-Advantaged Dividend Income Fund
EVT
$2.13B
$587K 0.35%
21,239
BDX icon
74
Becton Dickinson
BDX
$46.9B
$568K 0.34%
2,394
-78
-3% -$18.7K
EMR icon
75
Emerson Electric
EMR
$86.7B
$568K 0.34%
5,900

Similar funds

Penbrook Management's Q2 2021 Portfolio in Review

As of Q2 2021, Penbrook Management held 107 positions worth $167M, up 20% from $139M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Penbrook Management deployed $6.46M of net new capital in Q2 2021, opening 5 new positions and adding to 23 existing holdings. Its largest new stake was Nuvve Holding Corp: 1 share worth $2.85M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 25% a quarter earlier, followed by Healthcare and Energy.

On the sell side, the largest reduction was Microsoft, an estimated $1.19M trimmed.

  • Penbrook Management's largest Q2 2021 buy was Nuvve Holding Corp: 1 share worth $2.85M.
  • Penbrook Management added most to GrafTech in Q2 2021, an estimated $1.27M increase.
  • Penbrook Management's biggest Q2 2021 reduction was Microsoft, cutting an estimated $1.19M.
  • Penbrook Management fully exited Nuveen New York Municipal Value Fund 2 in Q2 2021, selling an estimated $543K.
  • Penbrook Management's ten largest holdings make up 39% of its $167M portfolio in Q2 2021.
  • Penbrook Management opened 5 new positions and closed 3 in Q2 2021.
  • Penbrook Management's portfolio value rose 20% quarter-over-quarter to $167M.

Based on Penbrook Management's 13F filing for Q2 2021, filed 27 Jul 2021.